Global harmonization task force leans to European principles
This article was originally published in Clinica
New international safety and performance principles proposed for medical devices are closer to those of Europe than the US, according to Kimber Richter, deputy director of the Center for Devices and Radiological Health's office of device evaluation.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.